Michael D Rothman CIDP Research Fund at Columbia University Medical Center

Description

The Michael D. Rothman CIDP Research Fund at Columbia University was established to help support critical research into the causes and cures of CIDP and other neuropathies. Under the direction of Drs. Thomas Brannagan and Louis Weimer, the Columbia Neuropathy Research Center (CNRC) is developing and testing several promising new therapies, including a pilot study of biomarkers in CIDP. The objective of this study is to identify a biomarker consistently found in all CIDP patients, which would be an extraordinarily valuable diagnostic tool, and aid tremendously in the treatment of CIDP patients.

Innovative research remains our greatest hope to eradicating CIDP and other neuropathies. With your involvement, CIDP research at Columbia University will flourish, giving new hope to patients with this disease and their families who care for them.